Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019 is a research paper published in JAMA Network Open (2022). On theSindex it has a DataRank of 0.661. It has been cited 81 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.661
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: U01 CA231840
National Institutes of Health
Grant: 5U01CA231840-03
Network Analysis for a Data-Driven Approach to Cancer Care
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals